Source link : https://newshealth.biz/health-news/two-sma-drugs-move-to-routine-nhs-funding/
NICE has recommended routine NHS access to nusinersen and risdiplam for spinal muscular atrophy, ending time-limited managed access schemes in place since 2019. Medscape News UK Source link : https://www.medscape.com/viewarticle/two-sma-drugs-move-routine-nhs-funding-2026a1000fnk?src=rss Author : Publish date : 2026-05-14 13:32:00 Copyright for syndicated content belongs to the linked Source.
The post Two SMA Drugs Move to Routine NHS Funding first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-14 13:32:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8